Search
for
Sort by
Research 30 of 1000+
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Table 1_Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients.docx
- Supplementary file 1_Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients.docx
- Finasteride-Induced Myalgia and HyperCKemia
- Cardioprotective effect of royal jelly on paclitaxel-induced cardio-toxicity in rats.
- Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo
- Management of Cutaneous and Extracutaneous Side Effects of Smoothened Inhibitor Therapy for Advanced Basal Cell Carcinoma
- Association of Anti-Signal Recognition Particle Myopathy with Systemic Lupus Erythematosus
- A serious side effect of a potentially widely used cosmetic product
- Comprehensive Case Analysis: Diagnosing and Managing Myositis in Newly Diagnosed Systemic Lupus Erythematosus Patients in Indonesia.
- Hoffman syndrome with the classic sign of myoedema and an unusual finding of systolic heart failure
- Baricitinib: A Review in Severe Alopecia Areata
- Lower Extremity Cramping and Palpitations in a 17-Year-Old Boy
- Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA) in a 56-Year-Old Patient With Silicone Breast Implants: A Case Report
- Macrocytosis and pseudoalbinism: Manifestations of selenium deficiency
- Comparative Study of Myocardial Biomarkers Among Women with and Without Polycystic Ovarian Syndrome (Pcos) in Nigeria
- Anaplasmosis concurrent with copper deficiency in a Salem Black kid
- Comprehensive Case Analysis: Diagnosing and Managing Myositis in Newly Diagnosed Systemic Lupus Erythematosus Patients in Indonesia
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib: A retrospective review of 29 patients
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience
- Use of Rituximab for Dermatomyositis Over Conventional Therapy: A Case Report
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- [Hypothyroid myopathy in a young adult].
- Treatment of Refractory Segmental Vitiligo and Alopecia Areata in a Child with Upadacitinib and NB-UVB: A Case Report
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective